Therapeutic genome editing: prospects and challenges
METADATA ONLY
Loading...
Author / Creator
Date
2015-02
Publication Type
Journal Article
ETH Bibliography
no
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Recent advances in the development of genome editing technologies based on programmable nucleases have substantially improved our ability to make precise changes in the genomes of eukaryotic cells. Genome editing is already broadening our ability to elucidate the contribution of genetics to disease by facilitating the creation of more accurate cellular and animal models of pathological processes. A particularly tantalizing application of programmable nucleases is the potential to directly correct genetic mutations in affected tissues and cells to treat diseases that are refractory to traditional therapies. Here we discuss current progress toward developing programmable nuclease-based therapies as well as future prospects and challenges.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
21 (2)
Pages / Article No.
121 - 131
Publisher
Nature
Event
Edition / version
Methods
Geographic location
Date collected
Date created
Subject
Organisational unit
09580 - Platt, Randall / Platt, Randall
Notes
Published online 5 February 2015.